2nd Mastering HR Summit 2011

26 - 27 October 2011, Amsterdam, Netherlands.
North West Business GroupNorth West Business Group invites to attend the 2nd Mastering HR 2011 Conference, geared towards Vice Presidents, Directors, and Managers involved in Talent, recruitment and compensation and benefits. Based on the success of the previous Mastering HR conference in March 2011, the hot topics for a one-stop shop approach to international HR issues have been combined.

Driven by increasing recognition of the importance of human capital in today's competitive market, the organization's expectation of HR is continuously getting higher. The role of HR is evolving from an operational department to a strategic one. HR professionals need to advance their skills and equip the team with new and ever-changing ideas. Attending this exclusive conference will bring together top experts from across Europe for a very intensive and interactive meeting. Benefit from the hands-on approach and unique case studies from top players in the industry. This forum sets a platform for practitioners from around the world to discuss and share strategies for their future success.

The event will focus on the most current topics in the HR industry such as:

  • A Cohesive Approach to Recruiting, Hiring and Accelerating Talent
  • Utilizing Social Media to Reach Specific Skill Set Employees
  • Evaluating Current Trends In Recruitment And Retention
  • How Connecting Performance Management And Talent is going to help you?
  • Using Talent Development Programs As A Vehicle For The Corporate Strategy
  • Recruiting the Best Talent By Selling More Than Just A Salary - The Role Of Culture
  • Effective Remuneration Planning To Succeed In a Tight Labour Market
  • Effectively Communicating Remuneration And Benefits To Employees
  • How Recognition and Reward Can Motivate Employees to Build and Deliver Authentic Brand Experiences

Joins some of the experts like:

  • Genzyme, Vice President HR - European Commercial, CDMA
  • TeliaSonera, Vice President & HR Business Partner
  • Santander, Head of Talent Development & Performance
  • SAP, Director Learning & Talent Management
  • KPN, HR Director
  • IBM HR, Director Benelux
  • Astellas Pharma, Director Human Resources
  • Accenture, Country Director HR
  • Pfizer, Talent Acquisition COE Lead
  • Heinz, Director Compensation & Benefits
  • Zurich Financial Services, UK Head of Resourcing
  • IBM, Workforce Partner Benelux
  • UBS, HR Executive Director
  • Magnate Global Group MGG, Group CHRO
  • European Personnel Selection Office, Director of EPSO
  • IBM HR, Director Benelux
  • And many more ...

Who should attend?
This conference is designed to attract key decision makers from the HR industry with key job titles including: Managing Directors, Country Managers, General Managers, Vice Presidents, Regional Directors/Heads, Directors, Department Heads, Managers, etc.

Benefits of attending include:

  • Hearing from experts actively working in the industry
  • Participating in the panel discussions
  • Quizzing industry experts on the ideas that worked
  • Exchanging ideas with senior professionals across Europe

For further information and registration, please visit:
http://www.nwbg.eu/all-events/2nd-master-hr-sumit-2011/

Most Popular Now

NextPoint Therapeutics announces $80 million Serie…

NextPoint Therapeutics, a biotechnology company developing a new world of precision immuno-oncology, announced today that it raised $80 million in Series B financing co-l...

AstraZeneca to acquire CinCor Pharma to strengthen…

AstraZeneca has entered into a definitive agreement to acquire CinCor Pharma, Inc. (CinCor), a US-based clinical-stage biopharmaceutical company, focused on developing no...

Time-restricted eating reshapes gene expression th…

Numerous studies have shown health benefits of time-restricted eating including increase in life span in laboratory studies, making practices like intermittent fasting a ...

Incurable liver disease may prove curable

Research led by Associate Professor Duc Dong, Ph.D., has shown for the first time that the effects of Alagille syndrome, an incurable genetic disorder that affects the li...

Scientists develop a cancer vaccine to simultaneou…

Scientists are harnessing a new way to turn cancer cells into potent, anti-cancer agents. In the latest work from the lab of Khalid Shah, MS, PhD, at Brigham and Women’s ...

Bayer to accelerate drug discovery with Google Clo…

Bayer AG and Google Cloud announced a collaboration to drive early drug discovery that will apply Google Cloud's Tensor Processing Units (TPUs), which are custom-develope...

Acquisition of Neogene Therapeutics completed

AstraZeneca has completed the acquisition of Neogene Therapeutics Inc. (Neogene), a global clinical-stage biotechnology company pioneering the discovery, development and ...

Study identifies potential new approach for treati…

Targeting iron metabolism in immune system cells may offer a new approach for treating systemic lupus erythematosus (SLE) - the most common form of the chronic autoimmune...

Nanotechnology may improve gene therapy for blindn…

Using nanotechnology that enabled mRNA-based COVID-19 vaccines, a new approach to gene therapy may improve how physicians treat inherited forms of blindness. A collabo...

Modified CRISPR-based enzymes improve the prospect…

Many genetic diseases are caused by diverse mutations spread across an entire gene, and designing genome editing approaches for each patient’s mutation would be impractic...

Pfizer expands 'An Accord for a Healthier World' p…

Pfizer Inc. (NYSE: PFE) announced that it has significantly expanded its commitment to An Accord for a Healthier World to offer the full portfolio of medicines and vaccin...

500,000 missed out on blood pressure lowering drug…

Nearly half a million people missed out on starting medication to lower their blood pressure during the COVID-19 pandemic, according to research supported by the British ...